PARAMETRIC PORTFOLIO ASSOCIATES LLC - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 177 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$9,693,000
+8.1%
400,201
+4.2%
0.01%0.0%
Q4 2021$8,967,000
+139.6%
384,207
+70.5%
0.01%
+150.0%
Q3 2021$3,743,000
-51.8%
225,320
-29.2%
0.00%
-50.0%
Q2 2021$7,763,000
+38.7%
318,306
+46.8%
0.00%
+33.3%
Q1 2021$5,596,000
-65.2%
216,890
-27.8%
0.00%
-70.0%
Q4 2020$16,069,000
+156.0%
300,576
+97.5%
0.01%
+100.0%
Q3 2020$6,278,000
-37.2%
152,193
-26.2%
0.01%
-37.5%
Q2 2020$9,990,000
+35.3%
206,115
+17.9%
0.01%
+14.3%
Q1 2020$7,384,000
+17.1%
174,770
+18.5%
0.01%
+40.0%
Q4 2019$6,307,000
+29.0%
147,428
+8.5%
0.01%
+25.0%
Q3 2019$4,891,000
+173.4%
135,892
+103.0%
0.00%
+300.0%
Q2 2019$1,789,000
+11.7%
66,927
+12.2%
0.00%0.0%
Q1 2019$1,601,000
+69.1%
59,638
+1.8%
0.00%0.0%
Q4 2018$947,000
-26.4%
58,559
-5.6%
0.00%0.0%
Q3 2018$1,287,000
+40.2%
62,001
+3.1%
0.00%0.0%
Q2 2018$918,000
-0.9%
60,138
+46.0%
0.00%0.0%
Q1 2018$926,000
-27.0%
41,203
-2.2%
0.00%0.0%
Q4 2017$1,269,000
-29.8%
42,147
-12.2%
0.00%
-50.0%
Q3 2017$1,807,000
+55.0%
47,977
+14.8%
0.00%
+100.0%
Q2 2017$1,166,000
-48.2%
41,797
-36.1%
0.00%
-66.7%
Q1 2017$2,250,000
+68.8%
65,443
+41.5%
0.00%
+50.0%
Q4 2016$1,333,000
-23.4%
46,235
-15.5%
0.00%
-33.3%
Q3 2016$1,740,000
+4.4%
54,705
+6.5%
0.00%0.0%
Q2 2016$1,667,000
+91.0%
51,346
+64.5%
0.00%
+200.0%
Q1 2016$873,000
-40.1%
31,222
-23.6%
0.00%
-50.0%
Q4 2015$1,457,000
+23.2%
40,864
+14.2%
0.00%0.0%
Q3 2015$1,183,000
-12.0%
35,776
+11.4%
0.00%
-33.3%
Q2 2015$1,345,000
+53.2%
32,126
+19.2%
0.00%
+50.0%
Q1 2015$878,000
+24.0%
26,952
+20.9%
0.00%
+100.0%
Q4 2014$708,000
+62.0%
22,301
+26.3%
0.00%0.0%
Q3 2014$437,000
+12.1%
17,664
+2.3%
0.00%0.0%
Q2 2014$390,000
-24.6%
17,274
-18.8%
0.00%0.0%
Q1 2014$517,000
-21.5%
21,268
-19.4%
0.00%
-50.0%
Q4 2013$659,000
-28.2%
26,389
-21.0%
0.00%0.0%
Q3 2013$918,000
+39.9%
33,417
-7.5%
0.00%0.0%
Q2 2013$656,00036,1260.00%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders